PON1 rs705379: Understanding This Genetic Variant
The rs705379 variant is a single nucleotide polymorphism located in the promoter region of the PON1 gene. It is primarily studied for its influence on the expression and activity levels of the paraoxonase-1 enzyme, which plays a role in antioxidant and metabolic processes.
What each genotype means
Lowest arylesterase activity
This genotype is associated with the lowest levels of arylesterase enzyme activity in the blood. Research into this variant, also known as -108C/T, suggests it may influence how the body processes certain compounds, though its clinical significance regarding reproductive health remains limited and requires further study.
This genotype is one of the common variations observed in the general population.
Intermediate arylesterase activity
Individuals with this genotype typically exhibit intermediate levels of arylesterase enzyme activity. While this variant has been studied for potential roles in metabolic and reproductive health, current evidence is limited and does not support using this information for diagnostic purposes.
This heterozygous genotype is frequently observed across diverse ancestral populations.
Highest arylesterase activity
This genotype is associated with the highest levels of arylesterase enzyme activity among the common variants of this gene. While higher enzyme activity is a documented physiological trait, the specific impact on long-term health outcomes remains a subject of ongoing scientific investigation.
This genotype is a common occurrence in the general population, consistent with the reported global minor allele frequency.
What is rs705379 and Where is it Located?
The variant rs705379 is a common genetic change found in the promoter region of the PON1 gene, which sits on human chromosome 7. In genetics, a promoter region is a segment of DNA that acts as a control switch, determining how much of a specific protein is produced by the cell. Because rs705379 is located in this regulatory area, it is often referred to as the -108C/T polymorphism. This means that at a specific position in the DNA sequence, some individuals carry a cytosine (C) while others carry a thymine (T). By altering this regulatory switch, the variant can influence the overall production levels of the PON1 enzyme in the body. Researchers track this specific site because it is one of the primary genetic markers used to understand how individual differences in DNA contribute to variations in enzyme function across different people.
The Role of the PON1 Gene
The PON1 gene provides instructions for making an enzyme called paraoxonase-1. This enzyme is primarily produced in the liver and is secreted into the bloodstream, where it associates with high-density lipoprotein (HDL), often called 'good' cholesterol. The primary function of paraoxonase-1 is to act as an antioxidant, helping to protect the body from oxidative stress by breaking down harmful oxidized lipids. Additionally, the enzyme has arylesterase activity, which allows it to hydrolyze various toxic compounds, including certain organophosphate insecticides. Because of these protective roles, the PON1 gene is a frequent subject of study in fields related to cardiovascular health, metabolic regulation, and toxicology. Variations in the gene, such as rs705379, are investigated to see if they lead to higher or lower levels of this protective enzyme, which could theoretically impact how an individual's body manages oxidative damage and metabolic stability.
Research Associations and Evidence Strength
Scientific research has explored the link between rs705379 and various health conditions, including metabolic disorders and reproductive health issues like polycystic ovary syndrome (PCOS). The evidence for these associations is currently considered limited. While some studies suggest that certain genotypes may correlate with differences in arylesterase activity, the clinical significance of these findings remains a subject of ongoing investigation. It is important to note that many genetic variants associated with complex conditions like PCOS have small effect sizes, meaning they contribute only a tiny fraction to the overall risk. Furthermore, results can vary significantly between different populations and ethnic groups. Because the current body of evidence is mixed and often requires large-scale studies to confirm, it is not possible to use this single variant to predict an individual's health outcomes or diagnose a medical condition. The scientific community continues to study how PON1 variants interact with environmental factors and other genes.
Population Frequency
The rs705379 variant is widely distributed across global populations. According to catalog data, the frequency of the variant is approximately 0.3815, though this can fluctuate depending on the specific ancestral background of the group being studied. Because it is a common polymorphism, many individuals carry at least one copy of the variant, and it is considered a standard part of human genetic diversity.
What You Can and Cannot Do With This Information
Understanding your genotype for rs705379 is an educational exercise in learning about your genetic makeup, but it does not provide a medical diagnosis. You cannot use this information to determine your risk for specific diseases or to guide personal health decisions. Genetic associations are statistical observations made across large groups of people and do not necessarily apply to any single individual. If you are concerned about your metabolic health, reproductive history, or potential exposure to environmental toxins, the most effective approach is to consult with a qualified healthcare provider. They can evaluate your personal and family medical history, perform necessary clinical tests, and provide guidance tailored to your specific needs. Never make changes to your diet, lifestyle, or medical treatments based on genetic data without first discussing them with a doctor or a registered dietitian, as they can help you interpret your health status in a safe and evidence-based manner.
How common is this variant?
The rs705379 variant is a common polymorphism with a reported population frequency of 0.3815, appearing frequently across diverse ancestral groups.
Frequently asked questions
Is rs705379 a diagnostic test for PCOS?
No, rs705379 is not a diagnostic test for polycystic ovary syndrome. While some research has explored potential associations between this variant and reproductive health, it is not used in clinical settings to diagnose or screen for PCOS.
Does my PON1 genotype affect my cholesterol levels?
The PON1 enzyme is associated with HDL cholesterol, but having a specific genotype for rs705379 does not automatically mean you have abnormal cholesterol levels. Cholesterol is influenced by a complex mix of genetics, diet, and lifestyle factors.
Can I change my PON1 activity levels?
PON1 activity is influenced by both genetics and environmental factors. While you cannot change your DNA, you should speak with a healthcare provider about lifestyle choices that support overall metabolic and cardiovascular health.
Where can I find more information about my genetic results?
If you have received genetic testing results, you should consult with a genetic counselor or your primary care physician. They are trained to help you interpret your results in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs705379?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29